From November 3, 2023 to December 7, 2023, the company has repurchased 1,550,900 shares, representing 0.38% for CNY 29.99 million. With this, the company has completed the repurchase of 1,550,900 shares, representing 0.38% for CNY 29.99 million under the buyback announced on November 4, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.3 CNY | +2.97% | +2.19% | -13.67% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.67% | 898M | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- 603439 Stock
- News GuiZhou SanLi Pharmaceutical Co.,Ltd
- Tranche Update on Guizhou Sanli Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 4, 2023.